David McArthur
Corporate Officer/Principal bei 3 SIXTY RISK SOLUTIONS LTD.
Profil
David McArthur is currently a Director at African Cannabis Corp., Chief of Staff at Canada Department of Natural Resources, and Chief Corporate Affairs Officer at 3 Sixty Risk Solutions Ltd.
He previously worked as Chief of Staff at Indigenous & Northern Affairs Canada and Department of Canadian Heritage.
Aktive Positionen von David McArthur
| Unternehmen | Position | Beginn |
|---|---|---|
| 3 SIXTY RISK SOLUTIONS LTD. | Corporate Officer/Principal | - |
| Canada Department of Natural Resources | Personalreferent | - |
African Cannabis Corp.
 African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von David McArthur
| Unternehmen | Position | Ende |
|---|---|---|
| Indigenous & Northern Affairs Canada | Personalreferent | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| 3 SIXTY RISK SOLUTIONS LTD. | Finance |
| Private Unternehmen | 3 |
|---|---|
| Canada Department of Natural Resources | Government |
| Indigenous & Northern Affairs Canada | |
African Cannabis Corp.
African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Health Services |
